Candel Therapeutics Inc (CADL)
8.615
-0.14
(-1.54%)
USD |
NASDAQ |
Dec 23, 16:00
8.73
+0.12
(+1.33%)
After-Hours: 20:00
Candel Therapeutics Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc | -2.057B |
| AnaptysBio Inc | 58.62M |
| Bristol-Myers Squibb Co | -219.00M |
| Inovio Pharmaceuticals Inc | 14.08M |
| NovaBay Pharmaceuticals Inc | -0.002M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.573M |
| Cash from Financing (Quarterly) | 1.677M |
| Free Cash Flow | -28.69M |
| Free Cash Flow Per Share (Quarterly) | -0.2053 |
| Free Cash Flow Yield | -11.09% |